MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jnma.2026.01.007

Медицинская библиотека · Journal of the National Medical Association · 2026

Evaluation of Helicobacter pylori infection and clinical features in multiple sclerosis patients coexisting with vitiligo: Case-series.

Aghaei Maryam, Aghaei Shahrzad, Shahmoradi Zabihollah, Heidari Asieh, Ashtari Fereshteh, Hejazi Seyed Hossein

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Multiple Autoimmune Syndrome (MAS) involves at least three distinct autoimmune diseases. MAS' exact cause is unknown, however, genetic, immunologic, environmental, and infectious factors like Helicobacter pylori (H.pylori) are involved in its pathophysiology. Hence, in the current study, we described the demographic, and clinical characteristics of Multiple Sclerosis (MS) patients coexisting with vitiligo. Furthermore, we investigated the relationship between H. pylori eradication and patients' clinical improvement.

MATERIALS AND

METHODS

In this case-series study, eight female MS patients with clinically confirmed vitiligo were assessed for demographic and clinical characteristics via questionnaires and medical records. H. pylori infection also was evaluated using ELISA and stool antigen (HpSag) tests, and positive cases received eradication therapy.

RESULTS

The mean onset ages for MS and vitiligo were 23.12 ± 5.27 and 26.75 ± 4.97 years, with disease durations of 10.4 and 6.8 years, respectively. Six patients (75%) had an active vitiligo, and only one had active MS. Family history of MS and vitiligo was observed in 37.5% and 50% of patients, while 87.5% had other autoimmune diseases in their families. The mean H.pylori IgG and IgM levels were 15.58 ± 13.63 and 0.43 ± 0.31, respectively and H. pylori infection was detected in 25% of patients by either serology or stool antigen test, and no active vitiligo was observed post-eradication.

CONCLUSION

Since, our findings showed a potential association between H. pylori infection and the pathophysiology of vitiligo, eradication therapy may be used as a complementary approach alongside standard vitiligo treatments or even MS in MAS patients.

Для цитирования: Aghaei Maryam, Aghaei Shahrzad, Shahmoradi Zabihollah, Heidari Asieh, Ashtari Fereshteh, Hejazi Seyed Hossein. Evaluation of Helicobacter pylori infection and clinical features in multiple sclerosis patients coexisting with vitiligo: Case-series.. Journal of the National Medical Association. 2026. DOI: 10.1016/j.jnma.2026.01.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.